Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Clark-Snow

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
ONS News|May 28, 2005
Multidisciplinary oncology panel develops international antiemetic consensus guidelinesRebecca Clark-Snow, Cynthia N Rittenberg
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 6, 2017
Chemotherapy-induced nausea and vomiting (CINV) and adherence to antiemetic guidelines: results of a survey of oncology nursesRebecca Clark-Snow, Mary Lou Affronti, Cynthia N Rittenberg
Cancer Medicine|May 24, 2018
Rolapitant for the prevention of nausea in patients receiving highly or moderately emetogenic chemotherapyRudolph M Navari, Bernardo L Rapoport, Dan Powers, et al.
Future Oncology (London, England)|April 21, 2021
Single-dose netupitant/palonosetron versus 3-day aprepitant for preventing chemotherapy-induced nausea and vomiting: a pooled analysisRudolph M Navari, Gary Binder, Erminio Bonizzoni, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 10, 2024
MASCC 2023 Patient-Centered Antiemetic Guidelines and Education Statements: an evidence-based and consensus resource for patientsMary Lou Affronti, Jiyeon Lee, Alex Molassiotis, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 13, 2004
Antiemetics in children receiving chemotherapyFausto Roila, Petra Feyer, Ernesto Maranzano, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 31, 2016
2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potentialIan Olver, Christina H Ruhlmann, Franziska Jahn, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 17, 2023
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomitingBernardo Leon Rapoport, Jørn Herrstedt, Rebecca Clark Snow, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 19, 2023
2023 updated MASCC/ESMO consensus recommendations: controlling nausea and vomiting with chemotherapy of low or minimal emetic potentialIan Olver, Rebecca Clark-Snow, Christina H Ruhlmann, et al.
The Oncologist|March 13, 2020
Phase IIIb Safety and Efficacy of Intravenous NEPA for Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Patients with Breast Cancer Receiving Initial and Repeat Cycles of Anthracycline and Cyclophosphamide (AC) ChemotherapyLee Schwartzberg, Rudolph Navari, Rebecca Clark-Snow, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
ONS News|May 28, 2005
Multidisciplinary oncology panel develops international antiemetic consensus guidelinesRebecca Clark-Snow, Cynthia N Rittenberg
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 6, 2017
Chemotherapy-induced nausea and vomiting (CINV) and adherence to antiemetic guidelines: results of a survey of oncology nursesRebecca Clark-Snow, Mary Lou Affronti, Cynthia N Rittenberg
Cancer Medicine|May 24, 2018
Rolapitant for the prevention of nausea in patients receiving highly or moderately emetogenic chemotherapyRudolph M Navari, Bernardo L Rapoport, Dan Powers, et al.
Future Oncology (London, England)|April 21, 2021
Single-dose netupitant/palonosetron versus 3-day aprepitant for preventing chemotherapy-induced nausea and vomiting: a pooled analysisRudolph M Navari, Gary Binder, Erminio Bonizzoni, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 10, 2024
MASCC 2023 Patient-Centered Antiemetic Guidelines and Education Statements: an evidence-based and consensus resource for patientsMary Lou Affronti, Jiyeon Lee, Alex Molassiotis, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 13, 2004
Antiemetics in children receiving chemotherapyFausto Roila, Petra Feyer, Ernesto Maranzano, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 31, 2016
2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potentialIan Olver, Christina H Ruhlmann, Franziska Jahn, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 17, 2023
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomitingBernardo Leon Rapoport, Jørn Herrstedt, Rebecca Clark Snow, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 19, 2023
2023 updated MASCC/ESMO consensus recommendations: controlling nausea and vomiting with chemotherapy of low or minimal emetic potentialIan Olver, Rebecca Clark-Snow, Christina H Ruhlmann, et al.
The Oncologist|March 13, 2020
Phase IIIb Safety and Efficacy of Intravenous NEPA for Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Patients with Breast Cancer Receiving Initial and Repeat Cycles of Anthracycline and Cyclophosphamide (AC) ChemotherapyLee Schwartzberg, Rudolph Navari, Rebecca Clark-Snow, et al.
Pageof 2